S. R. McKeown
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 10
- Carcinogens and Genotoxicity Assessment 4
- Biotechnology top 5%
- Cancer Research and Treatments 3
- Molecular Biology top 10%
- DNA Repair Mechanisms 4
- ATP Synthase and ATPases Research 2
- Epigenetics and DNA Methylation 2
- Oncology top 10%
-
- Bladder and Urothelial Cancer Treatments 3
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- L H PattersonTracy RobsonV. J. McKelvey‐MartinR. CowenDennis J. McKennaStuart M. RaleighJenny WorthingtonD G Hirst
- Journals
- British Journal of Cancer (7 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Cardiovascular Research (1 paper)
- Partner nations
- United KingdomIrelandAustralia
In The Last Decade
S. R. McKeown
26 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 952
- Biotechnology 182
- Molecular Biology 882
- Oncology 317
- Pulmonary and Respiratory Medicine 301
Countries citing papers authored by S. R. McKeown
This map shows the geographic impact of S. R. McKeown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. R. McKeown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. R. McKeown more than expected).
Fields of papers citing papers by S. R. McKeown
This network shows the impact of papers produced by S. R. McKeown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. R. McKeown. The network helps show where S. R. McKeown may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. R. McKeown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 13 | |
| 2 | Defining normoxia, physoxia and hypoxia in tumours—implications for treatment responsebreakdown → | 2014 | 764 |
| 3 | 2011 | 34 | |
| 4 | 2008 | 27 | |
| 5 | 2008 | 95 | |
| 6 | 2007 | 130 | |
| 7 | 2006 | 39 | |
| 8 | 2006 | 36 | |
| 9 | 2003 | 82 | |
| 10 | 2003 | 29 | |
| 11 | 2001 | 41 | |
| 12 | 2000 | 65 | |
| 13 | 2000 | 149 | |
| 14 | 2000 | 20 | |
| 15 | 2000 | 29 | |
| 16 | Antitumour prodrug development using cytochrome P450 (CYP) mediated activation. | 1999 | 68 |
| 17 | 1998 | 80 | |
| 18 | 1998 | 63 | |
| 19 | 1992 | 10 | |
| 20 | 1989 | 9 |
About S. R. McKeown
S. R. McKeown is a scholar working on Cancer Research, Biotechnology and Pharmacology, having authored 26 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (10 papers), DNA Repair Mechanisms (4 papers), Carcinogens and Genotoxicity Assessment (4 papers), Cancer Research and Treatments (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), ATP Synthase and ATPases Research (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (952 citations), Biotechnology (182 citations) and Molecular Biology (882 citations). S. R. McKeown has collaborated with scholars based in United Kingdom, Ireland and Australia. Frequent co-authors include L H Patterson, Tracy Robson, V. J. McKelvey‐Martin, R. Cowen, Dennis J. McKenna, Stuart M. Raleigh, Jenny Worthington, D G Hirst, Carmel Mothersill and M.D. Burke. Their work appears in journals such as British Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.